Rong Li

机构：Peking University, Peking University Third Hospital, South China Institute of Collaborative Innovation · ORCID：0009-0002-0667-4367

发表论文 68 篇 · 总被引 3119 次 · h-index 19

代表论文

• MDSC checkpoint blockade therapy: a new breakthrough point overcoming immunosuppression in cancer immunotherapy (2025 · Cancer Gene Therapy · 被引 74)
• Lactate accumulation drives hepatocellular carcinoma metastasis through facilitating tumor-derived exosome biogenesis by Rab7A lactylation (2025 · Cancer Letters · 被引 38)
• SNHG1 , interacting with SND1 , contributes to sorafenib resistance of liver cancer cells by increasing m6A ‐mediated SLC7A11 expression and promoting aerobic glycolysis (2023 · Environmental Toxicology · 被引 13)
• Blockade of TIPE2-Mediated Ferroptosis of Myeloid-Derived Suppressor Cells Achieves the Full Potential of Combinatory Ferroptosis and Anti-PD-L1 Cancer Immunotherapy (2025 · Cells · 被引 10)
• CD86 costimulation enhances the antitumor activity of NKG2D CAR-Macrophages and synergizes with Anti-PD-L1 therapy to suppress prostate cancer progression (2025 · Cell Communication and Signaling · 被引 7)
• M6A-modified BFSP1 induces aerobic glycolysis to promote liver cancer growth and metastasis through upregulating tropomodulin 4 (2025 · Molecular Biomedicine · 被引 7)